Table S8. Univariate and multivariate analysis of factors associated with bone metastasis free survival in 223 patients with prostate adenocarcinoma. (PDF 10Â kb
Figure S4. (A and B) Real-time PCR of NANOG, BMI-1, SOX2 and OCT4 in the indicated cells. Transcript...
Figure S5. (A-C) Real-time PCR of BCL2, BCL-xL, Survivin and Mcl-1 in the indicated cells. Transcrip...
miR-210-3p expression is upregulated in bone metastatic PCa tissues and cells. (a) Percentages and n...
Table S7. Univariate and multivariate analysis of factors associated with overall survival in 245 pa...
Table S3. The basic information of 20 paired prostate adenocarcinoma patients for miR-133a-3p expres...
Table S5. The basic information of 245 prostate adenocarcinoma patients for miR-133a-3p expression a...
Table S4. The basic information of 48 patients with benign prostate lesions for miR-133a-3p expressi...
Figure S7. (A-C) ELISA analysis of EGF, bFGF, IGF1, IGF2, NGF and HGF concentration in the supernata...
Figure S6. Predicted miR-133a-3p targeting sequence and mutant sequences in 3â˛UTRs of EGFR, FGFR1,...
Table S2. A list of primers used in the reactions for real-time RT-PCR. (PDF 60Â kb
Figure S2. Low expression of miR-133a-3p correlates with poor clinicopathological characteristics an...
The relationship between miR-141-3p and clinicopathological characteristics in 141 patients with pro...
Figure S1. miR-133a-3p is downregulated in PCa tissues. (A) miR-133a-3p expression levels was decrea...
Figure S3. Real-time PCR analysis of miR-133a-3p expression in the indicated PC-3, C4-2B and VCaP ce...
Figure S8. AKT signaling was essential for the pro-tumor roles of silencing miR-133a-3p in PCa cells...
Figure S4. (A and B) Real-time PCR of NANOG, BMI-1, SOX2 and OCT4 in the indicated cells. Transcript...
Figure S5. (A-C) Real-time PCR of BCL2, BCL-xL, Survivin and Mcl-1 in the indicated cells. Transcrip...
miR-210-3p expression is upregulated in bone metastatic PCa tissues and cells. (a) Percentages and n...
Table S7. Univariate and multivariate analysis of factors associated with overall survival in 245 pa...
Table S3. The basic information of 20 paired prostate adenocarcinoma patients for miR-133a-3p expres...
Table S5. The basic information of 245 prostate adenocarcinoma patients for miR-133a-3p expression a...
Table S4. The basic information of 48 patients with benign prostate lesions for miR-133a-3p expressi...
Figure S7. (A-C) ELISA analysis of EGF, bFGF, IGF1, IGF2, NGF and HGF concentration in the supernata...
Figure S6. Predicted miR-133a-3p targeting sequence and mutant sequences in 3â˛UTRs of EGFR, FGFR1,...
Table S2. A list of primers used in the reactions for real-time RT-PCR. (PDF 60Â kb
Figure S2. Low expression of miR-133a-3p correlates with poor clinicopathological characteristics an...
The relationship between miR-141-3p and clinicopathological characteristics in 141 patients with pro...
Figure S1. miR-133a-3p is downregulated in PCa tissues. (A) miR-133a-3p expression levels was decrea...
Figure S3. Real-time PCR analysis of miR-133a-3p expression in the indicated PC-3, C4-2B and VCaP ce...
Figure S8. AKT signaling was essential for the pro-tumor roles of silencing miR-133a-3p in PCa cells...
Figure S4. (A and B) Real-time PCR of NANOG, BMI-1, SOX2 and OCT4 in the indicated cells. Transcript...
Figure S5. (A-C) Real-time PCR of BCL2, BCL-xL, Survivin and Mcl-1 in the indicated cells. Transcrip...
miR-210-3p expression is upregulated in bone metastatic PCa tissues and cells. (a) Percentages and n...